Remodeling without destruction: non-proteolytic ubiquitin chains in neural function and brain disorders
Alexis Zajicek1, Wei-Dong Yao2
1Departments of Psychiatry & Behavioral Sciences, and of Neuroscience & Physiology, State University of New York Upstate Medical University, Syracuse, NY, 13210, USA.
Molecular Psychiatry
|July 26, 2020
Summary
Non-proteolytic polyubiquitin chains are crucial for brain function, regulating neuronal plasticity and development. These underappreciated chains are increasingly recognized for their roles in brain diseases.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Ubiquitination is a key posttranslational modification regulating biological processes, including in the central nervous system (CNS).
- Polyubiquitin chains, particularly non-proteolytic ones, play critical roles in cellular signaling and protein regulation.
- These non-degradative chains are abundant in the brain but understudied in neuronal and synaptic functions.
Purpose of the Study:
- To review recent advances in understanding non-conventional ubiquitin chains in the brain.
- To highlight the roles of non-proteolytic polyubiquitin chains in neural development, function, and plasticity.
- To discuss the emerging roles of these chains in neurological diseases.
Main Methods:
- Literature review of recent studies on non-conventional ubiquitination in the CNS.
- Analysis of research on polyubiquitin chain types and their distinct cellular functions.
- Synthesis of findings related to neuronal plasticity, development, and disease.
Main Results:
- Non-proteolytic polyubiquitin chains regulate crucial neuronal processes like scaffolding and signal transduction.
- These chains are essential for neuronal function, plasticity, and neural circuit remodeling.
- Emerging evidence links non-conventional ubiquitination to various brain pathologies.
Conclusions:
- Non-proteolytic ubiquitin chains are vital, yet underappreciated, regulators of neuronal function and plasticity.
- Further research into these chains is critical for understanding brain health and disease.
- Targeting non-conventional ubiquitination pathways may offer new therapeutic strategies for neurological disorders.
Related Concept Videos
The Proteasome
1.4K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.4K
The Proteasome
9.8K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
9.8K
Covalently Linked Protein Regulators
8.4K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
8.4K
Neural Regulation
42.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.8K
Regulated Protein Degradation
8.5K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.5K
Amyloid Fibrils
11.4K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.4K


